[1]CurrentPatentAssignee:CHRONOSTHERAPEUTICSLIMITED-WO2019/43407,2019,A1
[1]CurrentPatentAssignee:CHRONOSTHERAPEUTICSLIMITED-WO2019/43407,2019,A1Locationinpatent:Page/Pagecolumn96;97
433283-22-8
133415-17-5
483315-67-9
133415-15-3
488-84-6 | D-Ribulose, 1.0M aq solution | AA006VWD | MFCD00149301
24255-98-9 | 4-Bromo-2-piperidinopyridine | AA006WNR | MFCD01646272
22620-34-4 | (5-Chloro-3-pyridinyl)methanol | AA006X5U | MFCD09743969
22509-02-0 | 2-Isopropyl-1-methyl-1h-imidazole | AA006XN5 | MFCD11053674
49754-15-6 | Diethyl malonyldicarbamate | AA006Y7G | MFCD00098229
218962-77-7 | H-P-Carboxy-phe(otbu)-oh | AA006YMP | MFCD01318767
21150-22-1 | Beta-amanitin | AA006Z0O | MFCD00151212
22871-75-6 | Boronic acid,1,1'-(1,4-naphthalenediyl)bis- | AA006ZGL | MFCD06801666
475272-13-0 | 4-Cyanomethoxyphenylboronic acid, pinacol ester | AA006ZXS | MFCD06795675
1344-95-2 | Silicic acid, calcium salt | AA0070EL | MFCD00015979